Found: 103
Select item for more details and to access through your institution.
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 2, p. 475, doi. 10.1007/s00432-021-03627-1
- By:
- Publication type:
- Article
Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 20, p. 2802, doi. 10.3390/healthcare11202802
- By:
- Publication type:
- Article
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 909, doi. 10.3390/ijms18050909
- By:
- Publication type:
- Article
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Potential Role of Liquid Biopsies in Advancing the Understanding of Neuroendocrine Neoplasms.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 403, doi. 10.3390/jcm10030403
- By:
- Publication type:
- Article
Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2854, doi. 10.3390/jcm9092854
- By:
- Publication type:
- Article
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 273, doi. 10.3390/jcm9010273
- By:
- Publication type:
- Article
Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 1630, doi. 10.3390/jcm8101630
- By:
- Publication type:
- Article
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-Term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
- Published in:
- Neuroendocrinology, 2022, v. 112, n. 3, p. 298, doi. 10.1159/000516958
- By:
- Publication type:
- Article
Liver Embolisation for Patients with Neuroendocrine Neoplasms: Systematic Review.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 4, p. 354, doi. 10.1159/000507194
- By:
- Publication type:
- Article
Identification of Areas for Improvement in the Management of Bone Metastases in Patients with Neuroendocrine Neoplasms.
- Published in:
- Neuroendocrinology, 2020, v. 110, n. 7/8, p. 688, doi. 10.1159/000504256
- By:
- Publication type:
- Article
Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial).
- Published in:
- Neuroendocrinology, 2019, v. 108, n. 4, p. 317, doi. 10.1159/000497330
- By:
- Publication type:
- Article
Colorectal Neuroendocrine Neoplasms: Areas of Unmet Need.
- Published in:
- Neuroendocrinology, 2019, v. 108, n. 1, p. 45, doi. 10.1159/000493767
- By:
- Publication type:
- Article
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.
- Published in:
- Neuroendocrinology, 2019, v. 108, n. 1, p. 7, doi. 10.1159/000493980
- By:
- Publication type:
- Article
Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 3, p. 211, doi. 10.1159/000477585
- By:
- Publication type:
- Article
68Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' Management.
- Published in:
- Neuroendocrinology, 2018, v. 106, n. 2, p. 128, doi. 10.1159/000472717
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy -- Chemotherapy.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 281, doi. 10.1159/000473892
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy -- Biotherapy and Novel Targeted Agents.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 266, doi. 10.1159/000471880
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 212, doi. 10.1159/000471879
- By:
- Publication type:
- Article
Appendiceal Goblet Cell Carcinoids: Management Considerations from a Reference Peritoneal Tumour Service Centre and ENETS Centre of Excellence.
- Published in:
- Neuroendocrinology, 2016, v. 103, n. 5, p. 500, doi. 10.1159/000440725
- By:
- Publication type:
- Article
Determination of the Optimal Echocardiographic Scoring System to Quantify Carcinoid Heart Disease.
- Published in:
- Neuroendocrinology, 2014, v. 99, n. 2, p. 85, doi. 10.1159/000360767
- By:
- Publication type:
- Article
Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27607-8
- By:
- Publication type:
- Article
Future therapeutic strategies in the treatment of extrapulmonary neuroendocrine carcinoma: a review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156870
- By:
- Publication type:
- Article
Supplemental parenteral nutrition in cancer care: why, who, when.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113691
- By:
- Publication type:
- Article
New face for a familiar friend: the deGramont regimen in the treatment of metastatic colorectal cancer given as an outpatient: a feasibility study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2002, v. 8, n. 2/3, p. 97, doi. 10.1191/1078155202jp092oa
- By:
- Publication type:
- Article
Should Patients with Resected Bile Duct Cancer Receive an Adjuvant Treatment?
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 4, p. 57, doi. 10.13032/tjop.2052-5931.100109
- By:
- Publication type:
- Article
Looking Beyond Chemotherapy in Patients with Advanced, Well-differentiated, Pancreatic Neuroendocrine Tumors.
- Published in:
- Journal of OncoPathology, 2014, v. 2, n. 1, p. 15, doi. 10.13032/tjop.2052-5931.100074
- By:
- Publication type:
- Article
Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920915299
- By:
- Publication type:
- Article
The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073679
- By:
- Publication type:
- Article
A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Biliary Tract Cancer: Implicated Immune-Mediated Pathways and Their Associated Potential Targets.
- Published in:
- Oncology Research & Treatment, 2018, v. 41, n. 5, p. 298, doi. 10.1159/000488997
- By:
- Publication type:
- Article
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2023, v. 35, n. 12, p. 1, doi. 10.1111/jne.13343
- By:
- Publication type:
- Article
High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 10, p. 1, doi. 10.1111/jne.13193
- By:
- Publication type:
- Article
ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 3, p. 1, doi. 10.1111/jne.13105
- By:
- Publication type:
- Article
Plasma Tie2 is a tumor vascular response biomarker for VEGF inhibitors in metastatic colorectal cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07174-1
- By:
- Publication type:
- Article
Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 4951, doi. 10.3390/cancers15204951
- By:
- Publication type:
- Article
Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4217, doi. 10.3390/cancers15174217
- By:
- Publication type:
- Article
Patients Undergoing Systemic Anti-Cancer Therapy Who Require Surgical Intervention: What Surgeons Need to Know.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3781, doi. 10.3390/cancers15153781
- By:
- Publication type:
- Article
Third-Line Palliative Systemic Therapy for Advanced Biliary Tract Cancer: Multicentre Review of Patterns of Care and Outcomes.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 3047, doi. 10.3390/cancers15113047
- By:
- Publication type:
- Article
Prospective Observational Study of Prevalence, Assessment and Treatment of Pancreatic Exocrine Insufficiency in Patients with Inoperable Pancreatic Malignancy (PANcreatic Cancer Dietary Assessment—PanDA).
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2277, doi. 10.3390/cancers15082277
- By:
- Publication type:
- Article
Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 738, doi. 10.3390/cancers15030738
- By:
- Publication type:
- Article
Targeted Therapies for Perihilar Cholangiocarcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1789, doi. 10.3390/cancers14071789
- By:
- Publication type:
- Article
Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice.
- Published in:
- Cancers, 2022, v. 14, n. 4, p. 1017, doi. 10.3390/cancers14041017
- By:
- Publication type:
- Article
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5758, doi. 10.3390/cancers13225758
- By:
- Publication type:
- Article
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant?
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4152, doi. 10.3390/cancers13164152
- By:
- Publication type:
- Article
The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3779, doi. 10.3390/cancers13153779
- By:
- Publication type:
- Article
Next-Generation Biomarkers for Cholangiocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3222, doi. 10.3390/cancers13133222
- By:
- Publication type:
- Article
Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters Using the Modified RAND/UCLA Delphi Process.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2375, doi. 10.3390/cancers12092375
- By:
- Publication type:
- Article